drugset / Trial / NCT01336569
Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on Timolol
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study was to assess the safety and intraocular pressure (IOP)-lowering efficacy of changing to DuoTrav® from prior timolol 0.5% monotherapy in participants with open-angle glaucoma or ocular hypertension.
Timeline
- Start
- 2011-02
- Primary completion
- 2012-03
- Completion
- 2012-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Travoprost/Timolol | Unknown | 0.004 % | Other |
| Subject | Travoprost/Timolol | Unknown | 0.5 % | Other |